Saudi Journal of Kidney Diseases and Transplantation, published by Wolters Kluwer Medknow Publications, serves as a vital resource in the fields of nephrology and transplantation, dedicated to advancing the understanding and treatment of kidney diseases. With an ISSN of 1319-2442 and E-ISSN 2320-3838, this esteemed peer-reviewed journal aims to facilitate scholarly exchange and promote innovative research since its inception in 2006. Recognized for its Open Access model since 2007, it enables widespread dissemination of critical findings, thereby enhancing the global impact of kidney-related research. With a solid reputation reflected in its current Q3 categorization in both Nephrology and Transplantation for 2023, the journal continues to contribute meaningfully to these essential medical fields. Researchers, clinical professionals, and students can access its wealth of information to further their knowledge and practice in kidney health and organ transplantation, vital components in the landscape of modern medicine.

Journal of Renal Injury Prevention, published by NIKAN RESEARCH INST, is an essential resource in the fields of nephrology and urology, catering to the growing need for specialized knowledge in the prevention and management of renal injuries. Since its establishment in 2017, this journal has worked diligently to contribute to the global discourse on renal health, exploring innovative strategies and emerging therapies. With an ISSN of 2345-2781 and an E-ISSN of 2345-2781, it aims to provide high-quality research that addresses critical aspects of kidney injuries and their prevention. While currently classified in the Q4 quartile for both nephrology and urology, the journal aspires to enhance its impact by nurturing robust discussions among researchers and clinicians alike. The journal is based in Isfahan, Iran, and welcomes submissions that advance our understanding of renal pathology. Given its commitment to the advancement of medical science, the Journal of Renal Injury Prevention is poised to play a key role in shaping future research and clinical practices in the field.

Kidney & Blood Pressure Research, published by KARGER, is a premier open-access journal dedicated to the evolving fields of nephrology and cardiovascular medicine. Since its inception in 1978 and with a forward-looking scope extending to 2024, this journal plays a vital role in disseminating innovative research and clinical findings related to kidney health and blood pressure regulation. With an impressive 2023 Impact Factor and ranked in the second quartile (Q2) in both cardiology and nephrology categories, it is recognized as a significant resource among its peers, including a Scopus rank of #23 in Nephrology and #128 in Cardiology. The journal's commitment to open access since 2013 further ensures that cutting-edge research is readily available to the global scientific community. Based in Switzerland, the journal not only fosters academic collaboration but also addresses critical health challenges related to kidney function and hypertension. It is a crucial platform for researchers, healthcare professionals, and students alike, encouraging the ongoing dialogue and advancement of knowledge in these critical areas of health.

The International Journal of Nephrology is a premier peer-reviewed journal published by HINDAWI LTD, dedicated to advancing the field of nephrology through the dissemination of high-quality research. With an ISSN of 2090-214X and an E-ISSN of 2090-2158, this open-access journal has been providing a platform for scholarly articles since 2010, ensuring that both researchers and practitioners have immediate access to the latest findings in kidney health and disease. As of 2023, it holds a reputable Q2 rating in the nephrology category, ranking 36th out of 81 journals in Scopus, placing it in the 56th percentile. The journal aims to foster innovation and collaboration within the nephrology community by covering a broad scope of topics, including clinical and experimental research, innovative treatments, and public health initiatives related to kidney disorders. Situated in the United States, the International Journal of Nephrology is committed to enhancing understanding and improving outcomes in nephrology by bridging academia with clinical practice, making it an essential resource for academics, clinicians, and students alike.

NEPHROLOGY DIALYSIS TRANSPLANTATION is a premier academic journal published by Oxford University Press that plays a vital role in disseminating cutting-edge research within the fields of nephrology and transplantation. With an impressive impact factor and recognition as Q1 in both these categories for 2023, the journal ranks among the top publications in medicine, enhancing its visibility among a global audience of researchers, healthcare professionals, and students. Established in 1986, the journal has maintained a commitment to publishing high-quality, peer-reviewed articles that contribute to the advancement of knowledge and practice in renal medicine. Although this journal does not offer open access options, it remains a highly regarded resource due to its rigorous selection process and influential contributions to the field. Scholars are encouraged to explore the journal’s extensive archive, spanning from 1986 to 2024, for invaluable insights and developments in nephrology and transplantation.

Jornal Brasileiro de Nefrologia is a distinguished open-access journal published by the Sociedade Brasileira de Nefrologia, catering to the dynamic field of nephrology. Since its inception, the journal has been a vital platform for disseminating cutting-edge research, clinical practices, and advancements in nephrology, particularly focusing on the Brazilian healthcare context. With an E-ISSN of 2175-8239, the journal has embraced open-access policies since 2009, promoting wider reach and accessibility for its readership. Operating out of São Paulo, Brazil, the journal holds a Q3 ranking in Nephrology as of 2023 and has contributed significantly to the academic landscape by showcasing innovative studies and discussions that shape nephrology practice. The journal not only serves as a resource for researchers but also supports nephrologists, clinicians, and students in their pursuit of knowledge, ensuring that critical developments in kidney health are shared widely. With annual publication cycles from 2010 to 2024, the Jornal Brasileiro de Nefrologia remains committed to advancing the discipline while engaging an international audience dedicated to improving patient care in nephrology.

SEMINARS IN DIALYSIS is a reputable peer-reviewed journal published by WILEY, focusing on advancements in the field of nephrology, particularly in the context of dialysis. With its ISSN 0894-0959 and E-ISSN 1525-139X, this journal serves as an essential resource for researchers, healthcare professionals, and students committed to exploring innovative practices and solutions in kidney health. Since its inception in 1988 and continuing to 2024, the journal has established itself in the Q2 category of nephrology, highlighting its significance in academic discourse, as reflected by its Scopus rank of #42 out of 81 in the field. Although not openly accessible, SEMINARS IN DIALYSIS offers crucial insights into clinical practices and research findings that shape the future of dialysis treatment, making it a cornerstone publication for those dedicated to improving patient outcomes in nephrology.

SEMINARS IN NEPHROLOGY, published by W B SAUNDERS CO-ELSEVIER INC, stands as a premier journal in the field of nephrology, with a notable impact factor in its category. With its dedicated scope spanning significant developments from 1981 to 2024, this journal provides an essential platform for researchers, clinicians, and students to explore critical advances in renal medicine. Noteworthy for its classification in the Q1 quartile of nephrology journals, SEMINARS IN NEPHROLOGY ranks #18 out of 81 in Scopus, placing it in the 78th percentile of its field, which underscores its influence and contribution to contemporary research. While it currently does not offer open access, the journal remains a vital resource for anyone seeking to deepen their understanding of nephrological advancements and complexities. With an established address located at 1600 John F. Kennedy Boulevard, Ste 1800, Philadelphia, PA 19103-2899, it continues to draw a global readership committed to the pursuit of knowledge in kidney health and disease.

The International Journal of Nephrology and Renovascular Disease is a prestigious peer-reviewed journal dedicated to advancing the field of nephrology and related renal research. Published by DOVE MEDICAL PRESS LTD, this open access journal has been a vital resource for the nephrology community since its inception in 2008. With a focus on innovative studies and emerging trends, the journal has established itself in the scholarly landscape, achieving an impressive Q2 ranking within the nephrology category according to the 2023 Scopus metrics, and positioning itself at rank #33 out of 81 journals in the field. The journal aims to provide a platform for both established researchers and emerging scholars to share their findings and insights, significantly contributing to improving patient outcomes and enhancing the understanding of renal health. As it continuously seeks to publish high-quality research that reflects the latest developments in the discipline, the International Journal of Nephrology and Renovascular Disease serves as an indispensable tool for anyone involved in nephrology research, clinical practice, and education.

Kidney Diseases is an esteemed open-access journal published by KARGER that has been at the forefront of nephrology research since its inception in 2015. With an impressive Scopus ranking of #13 out of 81 in the field of Medicine Nephrology, placing it in the top 84th percentile, the journal has established itself as a vital resource for researchers, clinicians, and students interested in advancing knowledge on kidney health, disorders, and innovative treatment strategies. This journal aims to disseminate cutting-edge findings and clinical insights over a converged publication span from 2019 to 2024, fostering global collaboration and dialogue within the scientific community. With its commitment to open access, Kidney Diseases ensures that critical research is freely accessible, promoting wider dissemination of knowledge and the development of effective therapeutic interventions.